DRUG ABUSE SCREEN, URINE 9 PANEL

Components
Includes Amphetamines, Barbiturates, Benzodiazepines, Cocaine (as Benzoylecgonine, Methadone, Opiates, Phencyclidine, Propoxyphene, and Cannabis (THC)
UDC9A: Screen only. If confirmation of initial test positive is desired, notify laboratory within 14 days.
UDC9C: Reflexed to a GCMS confirmation for positive results.
FT9: Forensic drug screen. Must be accompanied by appropriate chain of custody. Reflexed to a GCMS confirmation for positive results. Positive samples stored one year.

Specimen Required
Collect random urine.
Forensic: Send 50.0 mL urine (30.0 mL minimum) refrigerated in a screw-capped plastic urine container.
Clinical: Send 30.0 mL urine (15.0 mL minimum) refrigerated in a screw-capped plastic urine container.
Pediatric: Newborn minimum requires 1.0 mL urine for the initial test and 0.5-5.0 mL for positive confirmations.

Methodology
Enzyme Immunoassay/Gas Chromatography/Mass Spectrometry

Stability
Room Temperature: 48 hours; Refrigerated: 14 days; Frozen: 14 days

Reference Range
See Appendices

Performed
Sunday-Friday

Turnaround Time1 day
Test CodesUDC9A: Clinical screen only. If confirmation of initial test positive is desired, notify laboraotyr within 14 days. UDC9C: Positive screens reflexed to GCMS confirmation FT9: Forensic drug screen. Must be accompanied by appropriate chain of custody. Reflexed to a GCMS confirmation for positive results. Positive sample stored one year.
18-36330 (UDC9A) 18-36360 (UDC9C) 18-70240 (FT9)
CPT-4 Code (s)
80101 x 9
LOINC Codes
Amphetamines   3349-8  
Barbiturates   3377-9  
Benzodiazepines   3390-2  
Cocaine   3393-6  
Methadone   3773-9  
Opiates   3879-4  
Phencyclidine   3936-2  
Propoxyphene   19141-1  
Cannabis   3427-2  
Chain of custody   LOINC not available  

Warde
Medical
Laboratory